Posted by & filed under Company Analysis, Economic Analysis, Governments & Regulators, Growth & Valuation, Industry Analysis, Management Issues, Personal Finance.

Description: Regeneron said it could produce ‘hundreds of thousands’ of does per month by the end of the summer if trials of its cocktail coronavirus treatment prove successful.

Source: TheStreet.com

Date: Mar 17, 2020

Link: https://www.thestreet.com/investing/regeneron-surges-after-identifying-coronavirus-antibodies

Questions for discussion:

  • What does the report say about the pharmaceutical effort to stop the spread of the Coronavirus?
  • What are the benefits to the first company that develops and distributes a treatment?
  • How do you think the global experience with this virus outbreak will change our behaviors in the future?

Leave a Reply

Your email address will not be published.